Transcription factor Ets-1 regulates fibroblast growth factor-1-mediated angiogenesis in vivo: Role of Ets-1 in the regulation of the PI3K/AKT/MMP-1 pathway

Journal of Vascular Research

Volumn 43, Issue 4, 2006, Pages 327-337

  Forough, Reza ^a   Weylie, Brian ^a   Collins, Charles ^a   Parker, Janet L ^a   Zhu, James ^b   Barhoumi, Rola ^b   Watson, Dennis K ^c  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Angiogenesis; Chick chorioallantoic membrane; Fibroblast growth factor 1; Matrix metalloproteinase 1; Transcription activity assay; Transcription factor Ets 1; Vascularization

Indexed keywords

FIBROBLAST GROWTH FACTOR 1; INTERSTITIAL COLLAGENASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR ETS 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CHORIOALLANTOIS; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME REGULATION; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CATTLE; CELL LINE; CELL MOVEMENT; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; DNA, ANTISENSE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTOR 1; GENE EXPRESSION REGULATION; GENE SILENCING; MATRIX METALLOPROTEINASE 1; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN ARRAY ANALYSIS; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 33746696033     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093198     Document Type: Article

References (45)

1. Forough R, Wang X, Martinez-Lemus LA, Thomas D, Sun Z, Motamed K, Parker JL, Meininger GA: Cell-based and direct gene transfer-induced angiogenesis via a secreted chimeric fibroblast growth factor-1 (sp-FGF-1) in the chick chorioallantoic membrane (CAM). Angiogenesis 2003;6:47-54.
2. Forough R, Weylie B, Patel C, Ambrus S, Singh US, Zhu J: Role of AKT/PKB signaling in fibroblast growth factor-1 (FGF-1)-induced angiogenesis in the chicken chorioallantoic membrane (CAM). J Cell Biochem 2005;94:109-116.
3. Weylie B, Zhu J, Singh U, Ambrus S, Forough R: Phosphatidylinositide 3-kinase is important in late-stage fibroblast growth factor-1-mediated angiogenesis in vivo. J Vasc Res 2005;43:61-69.
4. Schena M, Shalon D, Davis RW, Brown PO: Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995;270:467-470.
5. Chee M, Yang R, Hubbell E, Berno A, Huang XC, Stern D, Winkler J, Lockhart DJ, Morris MS, Fodor SP: Accessing genetic information with high-density DNA arrays. Science 1996;274:610-614.
6. Humphery-Smith I, Blackstock W: Proteome analysis: genomics via the output rather than the input code. J Protein Chem 1997;16:537-544.
7. Hubbard MJ: Proteomic analysis of enamel cells from developing rat teeth: big returns from a small tissue. Electrophoresis 1998;19:1891-1900.
8. Iwasaka C, Tanaka K, Abe M, Sato Y: Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells. J Cell Physiol 1996;169:522-531.
9. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC: Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998;391:806-811.
10. Friesel RE, Maciag T: Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J 1995;9:919-925.
11. Simons M: Integrative signaling in angiogenesis. Mol Cell Biochem 2004;264:99-102.
12. Sano H, Forough R, Maier JA, Case JP, Jackson A, Engleka K, Maciag T, Wilder RL: Detection of high levels of heparin binding growth factor-1 (acidic fibroblast growth factor) in inflammatory arthritic joints. J Cell Biol 1990;110:1417-1426.
13. Lowe WL Jr, Florkiewicz RZ, Yorek MA, Spanheimer RG, Albrecht BN: Regulation of growth factor mRNA levels in the eyes of diabetic rats. Metabolism 1995;44:1038.
14. Partridge CR, Hawker JR Jr, Forough R: Overexpression of a secretory form of FGF-1 promotes MMP-1-mediated endothelial cell migration. J Cell Biochem 2000;78:487-499.
15. Delli Bovi P, Curatola AM, Kern FG, Greco A, Ittmann M, Basilico C: An oncogene isolated by transfection of Kaposi's sarcoma DNA encodes a growth factor that is a member of the FGF family. Cell Sci 1987;50:729-737.
16. Taira M, Yoshida T, Miyagawa K, Sakamoto H, Terada M, Sugimura T: cDNA sequence of human transforming gene hst and identification of the coding sequence required for transforming activity. Proc Natl Acad Sci USA 1987;84:2980-2984.
17. Dignam JD, Lebovitz RM, Roeder RG: Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983; 11:1475-1489.
18. Romano-Spica V, Georgiou P, Suzuki H, Papas TS, Bhat NK: NK role of ETS1 in IL-2 gene expression. J Immunol 1995;154:2724-2732.
19. Sementchenko VI, Schweinfest CW, Papas TS, Watson DK: ETS2 function is required to maintain the transformed state of human prostate cancer cells. Oncogene 1998;17:2883-2888.
20. Schelling ME, Meininger CJ, Hawker JR Jr, Granger HJ: Venular endothelial cells from bovine heart. Am J Physiol 1988;254:H1211-H1217.
21. Forough R, Lindner L, Partridge C, Jones B, Guy G, Clark G: Elevated 80K-H protein in breast cancer: a role for FGF-1 stimulation of 80K-H. Int J Biol Markers 2003;18:89-98.
22. Duterque-Coquillaud M, Leprince D, Flourens A, Henry C, Ghysdael J, Debuire B, Stehelin D: Cloning and expression of chicken p54c-ets cDNAs: the first p54c-ets coding exon is located into the 40.0 kbp genomic domain unrelated to v-ets. Oncogene Res 1988;2:335-344.
23. Forough R, Hawker JR Jr: Secondary transient transfection of stably transfected endothelial cells. Biotechniques 2000;29:720-726.
24. Wasylyk B, Hagman J, Gutierrez-Hartmann A: Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signaling pathway. Trends Biochem Sci 1998;23:213-216.
25. Trojanowska M: Ets factors and regulation of the extracellular matrix. Oncogene 2000;19:6464-6471.
26. Lelievre E, Lionneton F, Soncin F, Vandenbunder B: The Ets family contains transcriptional activators and repressors involved in angiogenesis. Int J Biochem Cell Biol 2001;33:391-407.
27. Watson DK, Li R, Sementchenko VI, Mavrothalassitis G, Seth A: The ETS genes; in Betino JR (ed): Encyclopedia of Cancer. Vol. 2, Academic Press, 2002.
28. Leprince D, Gegonne A, Coll J, de Taisne C, Schneeberger A, Lagrou C, Stehelin D: A putative second cell-derived oncogene of the avian leukaemia retrovirus E26. Nature 1983;306:395-397.
29. Nunn MF, Seeburg PH, Moscovici C, Duesberg PH: Tripartite structure of the avian erythroblastosis virus E26 transforming gene. Nature 1983;306:391-395.
30. Wernert N, Raes MB, Lassalle P, Dehouck MP, Gosselin B, Vandenbunder B, Stehelin D: c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am J Pathol 1992;140:119-127.
31. Tanaka K, Oda N, Iwasaka C, Abe M, Sato Y: Induction of Ets-1 in endothelial cells during reendothelialization after denuding injury. J Cell Physiol 1998;176:235-244.
32. Watanabe D, Takagi H, Suzuma K, Suzuma I, Oh H, Ohashi H, Kemmochi S, Uemura A, Ojima T, Suganami E, Miyamoto N, Sato Y, Honda Y: Transcription factor Ets-1 mediates ischemia- and vascular endothelial growth factor-dependent retinal neovascularization. Oncogene 2003;22:1795-1806.
33. Pourtier-Manzanedo A, Vercamer C, Van Belle E, Mattot V, Mouquet F, Vandenbunder B: Expression of an Ets-1 dominant-negative mutant perturbs normal and tumor angiogenesis in a mouse ear model. Am J Pathol 2004;164:1827-1835.
34. Sato Y: Role of ETS family transcription factors in vascular development and angiogenesis. Cell Struct Funct 2001;26:19-24.
35. Wasylyk C, Gutman A, Nicholson R, Wasylyk B: The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins. EMBO J 1991;10:1127-1134.
36. Kita D, Takino T, Nakada M, Takahashi T, Yamashita J, Sato H: Expression of dominant-negative form of Ets-1 suppresses fibronectin-stimulated cell adhesion and migration through down-regulation of integrin alpha? expression in U251 glioma cell line. Cancer Res 2001;61:7985-7991.
37. Valter MM, Hugel A, Huang HJ, Cavenee WK, Wiestler OD, Pietsch T, Wernert N: Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis. Cancer Res 1999;59:5608-5614.
38. Folkman J, Shing Y: Angiogenesis. J Biol Chem 1992;267:10931-10934.
39. Gutman A, Wasylyk B: The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites. EMBO J 1990;9:2241-2246.
40. Wasylyk B, Nordheim A: Ets transcription factors: partners in the integration of signal responses; in Papavassiliou AG (ed): Transcription Factors in Eukaryotes. Landes Bioscience, 1997, pp 253-286.
41. Westermarck J, Seth A, Kahari VM: Differential regulation of interstitial collagenase (MMP-1) gene expression by ETS transcription factors. Oncogene 1997;14:2651-2660.
42. Faux CH, Turnley AM, Epa R, Cappai R, Bartlett PF: Interactions between fibroblast growth factors and Notch regulate neuronal differentiation. J Neurosci 2001;21:5587-5596.
43. Qiao J, Bush KT, Steer DL, Stuart RO, Sakurai H, Wachsman W, Nigam SK: Multiple fibroblast growth factors support growth of the ureteric bud but have different effects on branching morphogenesis. Mech Dev 2001;109: 123-135.
44. Rosen GD, Barks JL, Iademarco MF, Fisher RJ, Dean DC: An intricate arrangement of binding sites for the Ets family of transcription factors regulates activity of the alpha 4 integrin gene promoter. J Biol Chem 1994;269:15652-15660.
45. Oda N, Abe M, Sato Y: ETS-1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin beta3. J Cell Physiol 1999;178:121-132.